Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,158) with videos related to
Page
of 116
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
December 10, 2019
Clinical quantification of the integrin αvβ6 by [<sup>18</sup>F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)
Pauline T Lukey, Christopher Coello, Roger Gunn, et al.
Clinical Rheumatology
|
January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Carmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
The Journal of Experimental Medicine
|
January 10, 2020
Dynamics of human monocytes and airway macrophages during healthy aging and after transplant
Adam J Byrne, Joseph E Powell, Brendan J O'Sullivan, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 18, 2014
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
Tamera J Corte, Gregory J Keir, Konstantinos Dimopoulos, et al.
Respiratory Research
|
July 14, 2019
Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort
Louise A Organ, Anne-Marie R Duggan, Eunice Oballa, et al.
The New England Journal of Medicine
|
May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
Toby M Maher, Shervin Assassi, Arata Azuma, et al.
Science Immunology
|
October 24, 2020
Itaconate controls the severity of pulmonary fibrosis
Patricia P Ogger, Gesa J Albers, Richard J Hewitt, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 10, 2021
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells
Yong Huang, Justin M Oldham, Shwu-Fan Ma, et al.
Thorax
|
April 23, 2016
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Paul F Mercer, Hannah V Woodcock, Jessica D Eley, et al.
Thorax
|
June 19, 2025
Basement membrane repair response biomarker PRO-C4 predicts progression in idiopathic pulmonary fibrosis: analysis of the PFBIO and PROFILE cohorts
Jannie M B Sand, Peder Frederiksen, Alison E John, et al.
Page
of 116
Search research articles
Search
Showing results (1071-1080 of 1,158) with videos related to
Sort By:
Page
of 116
European Journal of Nuclear Medicine and Molecular Imaging
|
December 10, 2019
Clinical quantification of the integrin αvβ6 by [<sup>18</sup>F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)
Pauline T Lukey, Christopher Coello, Roger Gunn, et al.
Clinical Rheumatology
|
January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Carmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
The Journal of Experimental Medicine
|
January 10, 2020
Dynamics of human monocytes and airway macrophages during healthy aging and after transplant
Adam J Byrne, Joseph E Powell, Brendan J O'Sullivan, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 18, 2014
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
Tamera J Corte, Gregory J Keir, Konstantinos Dimopoulos, et al.
Respiratory Research
|
July 14, 2019
Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort
Louise A Organ, Anne-Marie R Duggan, Eunice Oballa, et al.
The New England Journal of Medicine
|
May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
Toby M Maher, Shervin Assassi, Arata Azuma, et al.
Science Immunology
|
October 24, 2020
Itaconate controls the severity of pulmonary fibrosis
Patricia P Ogger, Gesa J Albers, Richard J Hewitt, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 10, 2021
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells
Yong Huang, Justin M Oldham, Shwu-Fan Ma, et al.
Thorax
|
April 23, 2016
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Paul F Mercer, Hannah V Woodcock, Jessica D Eley, et al.
Thorax
|
June 19, 2025
Basement membrane repair response biomarker PRO-C4 predicts progression in idiopathic pulmonary fibrosis: analysis of the PFBIO and PROFILE cohorts
Jannie M B Sand, Peder Frederiksen, Alison E John, et al.
Page
of 116